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Introduction
Albinism is a heterogeneous group of genetic hypopigmentary
disorders clinically divided into ocular albinism (OA)
and oculocutaneous albinism (OCA). OA mainly affects
pigmentation in the visual system and is considered to be a
mild form of OCA (King et al., 2002). All four types of OCA
discovered so far are associated with reduced/absent
pigmentation of the skin, hair and eyes, which occurs as a
consequence of mutations in genes involved in regulating
melanin biosynthesis. Three of the OCA distinctive phenotypes
known in humans have been well characterized: OCA1 (MIM
#203100), OCA2 (MIM #203200) and OCA3 (MIM #203290).
They have been mapped to distinct pigment genes encoding
tyrosinase (Tyr), the pink-eyed dilution (P) protein and
tyrosinase-related protein 1 (Tyrp1), respectively. OCA4 (MIM
#606574) is a very recently discovered form of OCA and is
associated with mutations in the underwhite (uw) gene, which
encodes the membrane-associated transporter protein (MATP)
(Newton et al., 2001). MATP is regulated at the transcriptional
level by Mitf, a basic helix-loop-helix transcription factor that
modulates the expression of a number of melanocyte-specific
genes, such as Tyr and Tyrp1 (Baxter and Pavan, 2002). The
uw mutation has been shown to significantly reduce the
melanin content of skin and hair in humans and in mice
(Lehman et al., 2000; Newton et al., 2001). MATP has 12
predicted membrane-spanning regions, as does the P protein
associated with OCA2.
OCA1 is an autosomal recessive disorder associated with
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Oculocutaneous albinism (OCA) type 4 is a newly identified
human autosomal recessive hypopigmentary disorder that
disrupts pigmentation in the skin, hair and eyes. Three
other forms of OCA have been previously characterized,
each resulting from the aberrant processing and/or sorting
of tyrosinase, the enzyme critical to pigment production in
mammals. The disruption of tyrosinase trafficking occurs
at the level of the endoplasmic reticulum (ER) in OCA1 and
OCA3, but at the post-Golgi level in OCA2. The gene
responsible for OCA4 is the human homologue of the
mouse underwhite (uw) gene, which encodes the membrane-
associated transporter protein (MATP). To characterize
OCA4, we investigated the processing and sorting of
melanogenic proteins in primary melanocytes derived from
uw/uw mice and from wild-type mice. OCA4 melanocytes
were found to be constantly secreted into the medium dark
vesicles that contain tyrosinase and two other melanogenic
enzymes, Tyrp1 (tyrosinase-related protein 1) and Dct
(DOPAchrome tautomerase); this secretory process is not
seen in wild-type melanocytes. Although tyrosinase was
synthesized at comparable rates in wild-type and in uw-
mutant melanocytes, tyrosinase activity in uw-mutant
melanocytes was only about 20% of that found in wild-type
melanocytes, and was enriched only about threefold in
melanosomes compared with the ninefold enrichment in
wild-type melanocytes. OCA4 melanocytes showed a
marked difference from wild-type melanocytes in that
tyrosinase was abnormally secreted from the cells, a
process similar to that seen in OCA2 melanocytes, which
results from a mutation of the pink-eyed dilution (P)
gene. The P protein and MATP have 12 transmembrane
regions and are predicted to function as transporters.
Ultrastructural analysis shows that the vesicles secreted
from OCA4 melanocytes are mostly early stage
melanosomes. Taken together, our results show that in
OCA4 melanocytes, tyrosinase processing and intracellular
trafficking to the melanosome is disrupted and the enzyme
is abnormally secreted from the cells in immature
melanosomes, which disrupts the normal maturation
process of those organelles. This mechanism explains the
hypopigmentary phenotype of these cells and provides new
insights into the involvement of transporters in the normal
physiology of melanocytes.
Key words: OCA4, Underwhite, Tyrosinase, Pigmentation, Albinism
Summary
Tyrosinase processing and intracellular trafficking is
disrupted in mouse primary melanocytes carrying the
underwhite (uw) mutation. A model for
oculocutaneous albinism (OCA) type 4
Gertrude-E. Costin1, Julio C. Valencia2, Wilfred D. Vieira1, M. Lynn Lamoreux3 and Vincent J. Hearing1,*
1Pigment Cell Biology Section, Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
2Pathology Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA
3Department of Veterinary Pathobiology, Texas A and M University, College Station, TX 77843, USA
*Author for correspondence (e-mail: hearingv@nih.gov)
Accepted 3 April 2003
Journal of Cell Science 116, 3203-3212 © 2003 The Company of Biologists Ltd
doi:10.1242/jcs.00598
Research Article
3204
deficient catalytic function of tyrosinase, the rate-limiting
enzyme in melanin biosynthesis, which results from mutations
of its encoding gene (TYR). Individuals with OCA1 show a
complete absence of pigment in their skin, eyes and hair; this
persists throughout life in the subtype OCA1A (Spritz et al.,
1990), whereas patients with subtype OCA1B have some
residual tyrosinase activity and thus gradually accumulate
minor amounts of pigment in their tissues (Oetting and King,
1999). OCA2 is the most common form of albinism; patients
are usually born with minimal pigmentation and become darker
during adulthood, finally showing minimal-to-moderate
pigmentation of their skin, hair and eyes (King, 1998; Manga
and Orlow, 1999). OCA3 is a rare form of OCA and patients
are born with minimal pigmentation but increase their
pigmentation as they age (Boissy et al., 1996; Manga et al.,
1997).
Studies using immortalized melanocytes derived from mice
carrying mutations in the genes responsible for OCA1 and
OCA3 have shown that these disorders are endoplasmic
reticulum (ER) retention diseases (Halaban et al., 2000;
Toyofuku et al., 2001a; Toyofuku et al., 2001b), wherein
tyrosinase is abnormally targeted for digestion in proteasomes
rather than being transferred to the Golgi apparatus for further
glycosylation. By contrast, studies of immortalized p-mutant
melanocytes (the model for OCA2) have shown that tyrosinase
in those cells is correctly processed through the Golgi, but it
is then secreted from the cells rather than being sorted to
melanosomes, thus showing that OCA2 is a hypopigmentary
disease resulting from altered intracellular trafficking of
tyrosinase (Manga et al., 2001; Chen et al., 2002; Toyofuku
et al., 2002). In this context, investigations into the molecular
basis of OCA4 are necessary to classify its mechanism into
one of the above types of diseases or into yet a new distinct
type.
In this study, we established primary melanocyte cultures
from mice carrying the uw/uw mutation at the underwhite locus
and from wild-type mice as a control. We show that in uw-
mutant melanocytes, tyrosinase processing through the ER and
Golgi is normal but that subsequent intracellular trafficking to
melanosomes is aberrant and a significant amount of tyrosinase
(and other melanogenic enzymes) is secreted from the cells in
vesicles and immature melanosomes, rather than melanin being
produced intracellularly in mature melanosomes. Thus, the
molecular basis of OCA4 shows a mechanism similar to that
involved in OCA2 but which occurs later in the melanosomal
maturation pathway, and in this context our results provide new
and important insights about the involvement of transporters in
the normal physiology of melanocytes.
Materials and Methods
Cell culture
Primary melanocytes from a/a; Uw/Uw; Tyr/Tyr (wild-type), a/a;
uw/uw; Tyr/Tyr (uw-mutant) and a/a; Uw/Uw; tyrc/tyrc (albino)
C57BL/6J mice were derived from dorsal skins of 1 day old mice
using a method previously reported (Tamura et al., 1987). Briefly,
dissected skins were washed twice with 70% ethanol, twice with
phosphate buffer saline (PBS) and were then individually incubated
in 6 ml of 0.25% trypsin at 4°C overnight. The epidermis was then
removed and the dermis was cut into small pieces and placed in Ham’s
F-10 medium (GIBCO, Grand Island, NY) for 2 days, at 37°C in a
humidified incubator with 5% CO2. The Ham’s F-10 medium
contained 10% fetal bovine serum (Atlanta Biologicals, Norcross,
GA), 10% newborn calf serum (Invitrogen, Carlsbad, CA), 0.1 mM
isobutylmethyl xanthine (Sigma, St Louis, MO), 10 m g/ml bovine
pituitary extract (Invitrogen), 48 nM 12-O-tetradecanoyl-phorbol-13-
acetate (Sigma), 1% penicillin/streptomycin/fungizone (Sigma) and 1
mM glutamine (Invitrogen). After 2 days, tissue debris was removed
by suction and the medium was changed and supplemented with 100
m g/ml geneticin G418 (G418 sulphate, Invitrogen). The geneticin
treatment lasted 2-3 days and was repeated intermittently if any
fibroblasts or keratinocytes persisted. Once pure colonies of
melanocytes were obtained, the medium was changed to
‘maintenance’ medium (Ham’s F-10) which contained 20% fetal
bovine serum, 0.1 mM dibutyryladenosine 3 ¢ ,5¢ -cyclic
monophosphate (Sigma), 10 m g/ml bovine pituitary extract, 48 nM
12-O-tetradecanoyl-phorbol-13-acetate, 1% penicillin/streptomycin/
fungizone and 1 mM glutamine. Cells were cultured in this medium
during the experiments.
Antibodies and enzymes
a PEP1, a PEP7 and a PEP8 are rabbit antisera raised in our laboratory
against the carboxyl-terminal peptides of Tyrp1, Tyr and Dct
(DOPAchrome tautomerase), respectively, as previously described
(Jiménez et al., 1989; Tsukamoto et al., 1992). Anti-rabbit IgG
horseradish peroxidase-linked (whole antibody) was from Amersham
Pharmacia Biotech (Piscataway, NJ), KDEL (SPA-827) polyclonal
antibody was purchased from StressGen (Victoria, BC, Canada) and
HMB-45 monoclonal antibody (Schaumburg-Lever et al., 1991;
Kikuchi et al., 1996) was purchased from DAKO (Carpinteria, CA).
Normal horse serum, normal goat serum, Texas-red anti-rabbit IgG
(H+L) and fluorescein isothiocyanate anti-mouse IgG (H+L) were all
from Vector (Burlingame, CA). Endoglycosidase H (EndoH) [EC
3.2.1.96, glycopeptide-D-mannosyl-N4-(N-acetyl-D-glucosaminyl)2-
asparagine 1,4-N-acetyl- b -glucosaminohydrolase] and peptide:N-
glycosidase F (PNGaseF) [EC 3.5.15.2, N-linked-glycopeptide-(N-
acetyl- b -D-glucosaminyl)-L-asparagine amidohydrolase] were from
New England Biolabs (Beverly, MA).
Cellular fractionation
Melanocytes were harvested with trypsin/EDTA and were washed
three times with cold PBS without CaCl2 and MgCl2. Cells were
solubilized in extraction buffer [1% Nonidet P-40 in PBS containing
a protease inhibitor cocktail (Boehringer Mannheim, Mannheim,
Germany)] for 1 hour on ice with occasional vortexing. The samples
were centrifuged at 14,000 g for 30 minutes at 4°C and the
supernatants were recovered and kept at –70°C for further
experiments. Protein concentrations were determined with the BCA
assay kit (Pierce, Rockford, IL) using bovine serum albumin as a
standard. 
To collect vesicles secreted by melanocytes, medium collected from
cells cultured for one week was centrifuged at 14,000 g for 30 minutes
at 4°C. The precipitates were solubilized in the extraction buffer and
were stored as described above.
To isolate the melanosome-enriched fraction, we used a method
previously described (Valverde et al., 1992). Briefly, the cells were
harvested, washed three times with PBS without CaCl2 and MgCl2
and lysed with 10 mM phosphate buffer, pH 7.2, containing 0.25 M
sucrose. A postnuclear supernatant was obtained by centrifugation at
700 g for 15 minutes at 4°C and was then further fractionated by
centrifugation at 14,000 g for 30 minutes at 4°C to yield the
melanosome-enriched pellet.
Metabolic labeling
Metabolic labeling and immunoprecipitation experiments were
Journal of Cell Science 116 (15)
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performed as previously reported (Kobayashi et al., 1994). Briefly,
melanocytes were cultured in 6-well tissue culture plates for 48 hours
before labeling. The cells were then incubated in methionine- and
cysteine-free Dulbecco’s Modified Eagle Medium (GIBCO) for 30
minutes at 37°C in a humidified incubator with 5% CO2, and were
then labeled for 1 hour with 0.5 mCi of [35S]-Methionine and Cysteine
Mixture (Redivue Promix, Amersham Biosciences). Following the 1
hour labeling period, the isotope-supplemented medium was removed
and complete medium containing 1 mM unlabeled methionine was
added. Media were then collected and the cells were harvested by
scraping immediately and after 3 or 24 hours of chase. The cells were
washed three times with PBS at 4°C and then solubilized for 1 hour
at 4°C in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl
containing 1% Nonidet P-40, 0,01% SDS and protease inhibitor
cocktail). [35S]-labeled cell lysates were precleared with 20 m l
Protein-G Sepharose 4 Fast Flow (Amersham) for 2 hours at 4°C with
mixing. The supernatants were collected following centrifugation at
5000 g for 1 minute at 4oC and then incubated with a PEP1 or a PEP7
for 2 hours at 4°C with mixing, as were the media collected at each
of the chase periods. The immune complexes were separated by
incubation with 20 m l Protein-G Sepharose 4 Fast Flow for 2 hours at
4°C and were further washed three times by centrifugation with the
lysis buffer. The final pellets were resuspended in sample buffer,
heated at 100°C for 5 minutes and centrifuged. The samples were
separated on 8% SDS-PAGE (sodium dodecyl sulphate-
polyacrylamide electrophoresis) gels. The dried gels were exposed in
a storage phosphor screen, scanned with a STORM Phosphor Imager
(Molecular Dynamics, Sunnyvale, CA) and then analyzed with the
Image Quant program.
Western blotting
For western blotting, samples were separated by electrophoresis under
reducing conditions, as previously described (Negroiu et al., 1999).
Briefly, lysates were mixed 1:2 (v/v) with sample buffer (BioRad,
Hercules, CA) containing 2-mercaptoethanol and were boiled for 10
minutes. Samples were separated by PAGE in SDS (8% Tris-glycine
gels, Invitrogen) and transferred to polyvinylidene difluoride
membranes (Millipore, Bedford, MA). Blots were blocked in 5% non-
fat milk in PBS for 1 hour at room temperature and were then
incubated with the appropriate first antibodies diluted 1:1000 in 1%
non-fat milk in PBS, for 1 hour at room temperature. After six washes
(10 minutes each) with 0.05% Tween 20 (Bio-Rad) in PBS, the blots
were incubated in anti-rabbit horseradish peroxidase-linked whole
antibody (1:1500) (Amersham) in 1% non-fat milk in PBS for 1 hour
at room temperature. After three further washes (10 minutes each)
with 0.05% Tween 20 in PBS, the immunoreactivity of the blots was
detected using an Enhanced ChemiLuminescence western blotting
detection kit (Amersham), according to the manufacturer’s
instructions.
EndoH and PNGaseF digestions
Samples to be digested were denatured in the EndoH- or PNGaseF-
denaturing buffer for 5 minutes at 100°C, cooled and then mixed
with 1/10 concentrated EndoH (0.5 M sodium citrate, pH 5.5) or
PNGaseF [0.5 M sodium phosphate, pH 7.5 containing 10% (v/v)
Nonidet P40] reaction buffers as previously described (Negroiu
et al., 1999). Samples were then digested with 500 units of EndoH
or PNGaseF, respectively, for 3 hours at 37°C and analyzed by
PAGE.
Melanogenic assays
Tyrosinase enzymatic activity was measured as described previously
(Hearing and Ekel, 1976). Briefly, 30 m l of each sample to be tested
were added to 10 m l phosphate buffer containing b -3,4-
dihydroxyphenylalanine (DOPA) as cofactor and 10 m l 0.25
mCi/mmol [U-14C]-tyrosine (NEN, Boston, MA). The reactions
(usually performed in duplicate or triplicate) were mixed and
incubated at 37°C for 3 hours. 40 m l of each sample were transferred
to Whatman 3MM filter paper discs and air dried. Each filter was then
washed three times in 0.1 N HCl, twice in 95% ethanol, once in
acetone and finally air-dried. Radioactive melanin retained by the
filters was determined in a Beckmann scintillation counter. Tyrosinase
activity is defined as pmol [14C]-tyrosine incorporated into
melanin/m g protein/hour at 37°C. 
The melanin content was measured using a modification of a
previously reported method (Siegrist and Eberle, 1986). Briefly,
melanocytes were cultured until they became confluent. They were
solubilized in lysis buffer containing the protease inhibitor cocktail
and protein concentrations were measured. Melanin pellets were
dissolved by incubation in 1 N NaOH at 37°C for 18 hours. Aliquots
of each sample were transferred to 96-well plates and were quantitated
by absorbance at 405 nm using an automatic microplate reader
(Molecular Devices, Sunnyvale, CA) and calibrated against a standard
curve generated using synthetic melanin (Sigma).
Immunohistochemical staining
Dual labeling, using immunofluorescence methods and laser scanning
confocal fluorescence microscopy, was used to evaluate the
localization of melanogenic proteins in wild-type and in uw/uw
melanocytes, as previously reported (Kushimoto et al., 2001). The
following antibody dilutions were used: a PEP1, 1:40; a PEP7, 1:40;
a PEP8, 1:40; KDEL, 1:10; HMB-45, 1:10. Melanocytes were plated
in 2-well Lab-Tek chamber glass slides (Nalge, Naperville, IL) 24-72
hours before each experiment and were fixed in 4% paraformaldehyde
for 15 minutes at 4°C. Cells were subsequently permeabilized with
methanol for 20 minutes at 4°C and then with 1% Triton X-100 for 3
minutes at room temperature (in experiments using the KDEL
antibody); all subsequent processing was done at room temperature.
After washing in PBS, cells were incubated in PBS containing 5%
normal serum (normal horse serum for monoclonal antibodies and
normal goat serum for polyclonal antibodies) for 1 hour as a blocking
step. The cells were then incubated overnight at 4°C with the
appropriate first antibody diluted in 2% normal serum. This step was
followed by incubation with the appropriate secondary antibody
(dilution, 1:100) for 1 hour. Nuclei were counterstained with 4 ¢ ,6¢ -
diamidino-2-phenylindole (DAPI) (Vector – blue fluorescence) for 15
minutes at room temperature. Immunoreactive cells were classified
into three categories according to whether they showed green, red or
yellow fluorescence (the latter color indicating colocalization of the
red and green signals). All preparations were examined with a Model
TCS4D, DMIRBE confocal microscope (Leica, Heidelberg,
Germany) equipped with argon and argon-krypton laser sources.
Controls included sections stained as detailed above, but omitting the
first antibody.
Electron microscopy
Confluent flasks of wild-type and of uw-mutant melanocytes were
fixed with 2% glutaraldehyde for 24 hours at 4°C, collected by
centrifugation and then washed twice with cold PBS. Further, analysis
of uw-mutant melanocytes was performed using the DOPA reaction,
an enzyme histochemical method to detect tyrosinase activity. For
DOPA staining, melanocytes were incubated for 3 hours at 37°C in
0.1% L-DOPA in 0.1 M phosphate buffer, pH 7.4, and fixed in 2%
glutaraldehyde as above. All samples were post-fixed in 1% osmium
tetroxide in 0.1 M phosphate buffer, pH 7.2, for 1 hour, dehydrated
through a graded ethanol series and embedded in PolyBed 812 at 60°C
for 48 hours. Ultrathin sections were cut and stained with uranyl
acetate and were then examined in a JEOL JEM-1200 EX electron
microscope.
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Results
Morphology of wild-type and uw-mutant primary
melanocytes in culture
Primary melanocytes derived from skins of wild-type and
from uw/uw mice were cultured under identical conditions,
and cellular viability and morphological characteristics were
noted. The growth of both types of melanocytes were quite
similar, with doubling times of approximately 10 days, and
their morphologies were quite stable over continued passage
(Fig. 1). Both types of melanocytes grew as an adherent
monolayer and were dendritic, although the uw-mutant
melanocytes were significantly larger and more dendritic
compared with wild-type melanocytes (cf. below). Bright-
field microscopy showed a very pigmented population of wild-
type melanocytes, whereas the uw-mutant cells were only very
lightly pigmented. Dark vesicles could be detected that
were constantly secreted into the medium by uw-mutant
melanocytes, whereas none were evident in the medium of
wild-type melanocytes. 
The pattern of melanin present in the extracellular medium
was similar to but distinct from that previously shown for
OCA2 p-mutant melanocytes (Potterf et al., 1998). In OCA2
p-mutant melanocytes, active tyrosinase was secreted into the
medium and the melanin produced in the medium was of very
low molecular weight and could not be sedimented by
centrifugation. By contrast, the pigment present in the medium
of uw-mutant melanocytes was in large particles (Fig. 1F)
that could be readily sedimented by centrifugation (Fig. 1H).
We next characterized the nature of tyrosinase synthesis
and processing to elucidate the intracellular mechanism(s)
responsible for the hypopigmentation of uw-mutant
melanocytes.
Subcellular distribution of tyrosinase activity and
melanin in wild-type and uw-mutant melanocytes
Wild-type and uw-mutant melanocytes were cultured until they
became confluent, and they were then fractionated and
solubilized in lysis buffer. Tyrosinase activity was measured in
the cell extracts and also in the melanosome and secreted
vesicle fractions (Table 1). In wild-type melanocytes, the
specific activity of tyrosinase in melanosomes was
approximately ninefold higher than in the cell extract, which
is the normal distribution pattern for tyrosinase trafficking.
Tyrosinase activity in the vesicle fraction secreted by wild-type
melanocytes was very low and represented less than 1% of the
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Fig. 1. Characteristics of wild-type and uw-mutant primary murine melanocytes in culture. (A,B) Phase contrast photomicrographs of wild-type
and uw-mutant melanocytes. (C,D) Bright-field microphotographs emphasizing the pigmentation of wild-type and uw-mutant melanocytes.
(E,F) Bright-field microphotographs showing the pigmented vesicles secreted by uw-mutant melanocytes into the medium (arrows) and their
absence in the medium of wild-type melanocytes. All photomicrographs are shown at the same magnification. (G) Media were collected from
wild-type and from uw-mutant melanocytes, and were centrifuged to show the similar appearance of those samples (i.e. no soluble melanin was
present). (H) Pigmented vesicles released into the medium by uw-mutant melanocytes can be readily sedimented by centrifugation, a process
not seen in wild-type melanocytes. (I) Melanin content of extracts of wild-type and uw-mutant melanocytes.
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activity seen in the total extract. By contrast, tyrosinase activity
in extracts of uw-mutant melanocytes was significantly lower
(about fivefold lower) than that found in wild-type
melanocytes. Tyrosinase activity in melanosomes of uw-
mutant melanocytes was only threefold higher than that found
in the total cell extract, and more than 5% of the enzyme
activity was present in the secreted vesicle fraction. The total
melanin content in uw-mutant melanocytes is negligible
compared with wild-type melanocytes (Table 1), which is
consistent with the report of Lehman et al. (Lehman et al.,
2000). 
Synthesis and processing of melanogenic proteins in
uw-mutant and wild-type melanocytes
Thus, the melanin content of uw-mutant OCA4 melanocytes is
consistent with their hypopigmented phenotype and also with
the reduced levels of tyrosinase and melanin found in OCA1,
OCA2 and OCA3 melanocytes. To further study the
mechanism behind that reduction, we used metabolic labeling
and western immunoblotting to examine the synthesis and
processing of tyrosinase in uw-mutant compared with wild-
type melanocytes. As shown in Fig. 2, the amount of tyrosinase
synthesized (at 0 chase time) by wild-type and by uw-mutant
melanocytes was virtually identical, showing that there was no
defect in tyrosinase gene transcription or translation, as
expected. Quantitation of the 64 kDa band representing the
newly synthesized tyrosinase revealed that the amount of
tyrosinase synthesized by uw-mutant melanocytes represents
~90% the level produced by wild-type melanocytes (n=4
independent experiments). Tyrosinase is synthesized as a 55
kDa polypeptide, which almost instantly undergoes early
glycosylation events in the ER and is seen as a 64 kDa band.
The fully glycosylated mature form of the enzyme is 68 kDa
in size. In fact, the synthesis and processing of tyrosinase from
the immature form to the mature form was complete within 3
hours in wild-type and in uw-mutant melanocytes and was
strikingly similar at that time. However, the stability of
tyrosinase was markedly different, with virtually 100% of the
tyrosinase remaining in wild-type melanocytes after 24 hours,
but very little remaining in uw-mutant cells. For comparison,
the pattern for OCA1 melanocytes is shown, wherein
tyrosinase was synthesized at the same rate as in wild-type and
in uw-mutant melanocytes. However, tyrosinase was not
processed to the mature form correctly and
was then quickly degraded, as previously
reported (Toyofuku et al., 2001b). 
Similar patterns of Tyrp1 synthesis and
processing are shown for comparison, and
no significant differences in Tyrp1 labeling
were seen between the wild-type and OCA4
(or OCA1) melanocytes. The synthesis,
processing and stability of Dct was also
virtually identical in all three types of
melanocytes (data not shown).
Western blot analysis revealed that
tyrosinase was detectable predominantly in
the mature 68 kDa form in the whole cell
extract and only in the mature form in
melanosomes of wild-type melanocytes, and
none was detected in the secreted vesicle
fraction (Fig. 3). By contrast, tyrosinase was
detectable not only in the 68 kDa form in the
cell extract and in melanosomes of uw-
mutant melanocytes but also in the secreted
vesicle fraction. Interestingly, Tyrp1,
although processed correctly and found in
melanosomes of uw-mutant melanocytes,
was also present in abundance in the
secreted vesicle fraction of those uw-mutant
Table 1. Tyrosinase activity and melanin content in subcellular fractions of wild-type vs uw-mutant melanocytes
Wild-type melanocytes Uw-mutant melanocytes
Tyrosinase activity Protein concentration Tyrosinase activity Protein concentration 
Fraction (pmol/m g protein/h) (m g/m l) (pmol/ m g protein/h) (m g/m l)
Cell extract 66.61±0.50 0.53±0.00 14.27±2.26 0.94±0.01
Melanosomes 590.99±0.01 0.37±0.00 46.92±0.45 0.14±0.00
Secreted vesicles 0.51±0.16 0.27±0.01 0.88±0.66 0.11±0.00
Melanin content Protein concentration Melanin content Protein concentration
(m g/m g protein) (m g/m l) (m g/m g protein) (m g/m l)
2.79±0.06 1.30±0.01 0.01±0.00 2.74±0.11
Fig. 2. Metabolic pulse-chase labeling of wild-type and uw-mutant melanocytes. Wild-
type, uw-mutant and Tyrc albino primary melanocytes were labeled for 1 hour with an
[35S]-methionine and cysteine mixture, harvested at the chase times indicated, solubilized
and immunoprecipitated using specific antibodies for tyrosinase and Tyrp1, respectively.
Immune complexes were separated by SDS-PAGE, and immunoprecipitated bands were
visualized as detailed in the Materials and Methods section.
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cells but was not found in the secreted vesicle fraction of wild-
type melanocytes. Similar patterns of Dct distribution were
seen in those vesicles (not shown).
Subcellular trafficking of tyrosinase in OCA4
melanocytes
To examine more closely the mechanism(s) by which
tyrosinase is aberrantly secreted from the uw-mutant
melanocytes, we assessed the sensitivity of tyrosinase to two
different glycosidases. EndoH is an enzyme that removes high
mannose-type carbohydrates from N-linked glycoproteins, a
conversion that occurs in the medial Golgi region. When
proteins are correctly processed through the ER and Golgi, they
become resistant to EndoH, and sensitivity to EndoH indicates
the presence of proteins that have not yet been processed
beyond the ER. By contrast, PNGaseF removes all
carbohydrate residues and reveals the native polypeptide size
of the protein. When digested with EndoH (Fig. 3), the mature
68 kDa form of tyrosinase from the cell extract of uw-mutant
melanocytes was almost completely resistant to EndoH but was
completely digested with PNGaseF, showing a pattern virtually
identical to that of wild-type melanocytes.
Western blot analysis of tyrosinase in melanosomes of wild-
type and uw-mutant melanocytes revealed that the mature 68
kDa band was EndoH resistant, as expected, whereas digestion
with PNGaseF generated a single strong 55 kDa band
representing the fully deglycosylated form. Similarly,
tyrosinase in the secreted vesicle fraction was resistant to
EndoH but could be fully digested to the 55 kDa nascent
polypeptide by PNGaseF. Thus, tyrosinase found in
melanosomes and in vesicles secreted from uw-mutant
melanocytes is EndoH resistant, showing that it has been
processed correctly through the ER. Similar digestions of
Tyrp1 (Fig. 3) and Dct (data not shown) showed comparable
processing patterns.
Taken together, the sum of these results suggests that
tyrosinase (and Tyrp1 and Dct) are processed correctly through
the ER and Golgi in uw-mutant melanocytes but that a
significant portion of those melanogenic enzymes are secreted
from uw-mutant melanocytes. Thus, the subcellular
distribution and enzyme functions of melanosomal proteins are
distinctly affected by this mutation in the uw gene.
Subcellular distribution of melanogenic proteins in uw-
mutant melanocytes
To investigate the subcellular localization of melanogenic
proteins in uw-mutant OCA4 melanocytes, we used
immunohistochemical staining to compare their distribution
with HMB-45, a marker for early (stage II) melanosomes
(Schaumburg-Lever et al., 1991; Kushimoto et al., 2001) and
KDEL, a marker for the ER (Fig. 4). Tyrosinase, Tyrp1 and
Dct were detected by red fluorescence, and HMB-45 and
KDEL were detected by green fluorescence; in the merged
images, yellow indicates colocalization of the two signals.
In wild-type primary melanocytes, the majority of tyrosinase
was found in granules distributed throughout the cytoplasm
(mainly in the dendrites), as well as in the perinuclear area
where the ER and stage I melanosomes are found. Some
tyrosinase colocalized with the ER marker KDEL but most of
it was in the particulate structures. Similar staining patterns
were observed for Tyrp1 and for Dct in those wild-type
melanocytes. These data confirm that the melanogenic proteins
are processed in the ER and are then distributed primarily in
melanosomes of wild-type primary melanocytes according to
their expression level, as previously shown for immortalized
melanocytes (Toyofuku et al., 2001b; Toyofuku et al., 2002).
Confocal microscopy of uw-mutant melanocytes showed
dramatic differences compared with wild-type melanocytes. As
noted above, these cells were more dendritic and grew to much
larger sizes than wild-type melanocytes, and this was
particularly evident when they were cultured on glass. All three
melanogenic proteins (Tyr, Tyrp1 and Dct) were distributed
throughout the cytoplasm of uw-mutant melanocytes and
accumulated in the perinuclear area, as in wild-type
melanocytes. Colocalization of tyrosinase, Tyrp1 and Dct with
the ER marker KDEL indicates that the melanogenic proteins
reach the ER compartment in uw-mutant melanocytes.
However, in contrast to wild-type melanocytes, there was
little co-staining of tyrosinase with HMB-45, suggesting a
trafficking defect later in the secretory pathway, before delivery
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Fig. 3. Western blot analysis of
melanogenic protein glycosylation in
subcellular fractions of wild-type and of
uw-mutant melanocytes. Equal amounts of
protein (0.1 m g/lane) from cell extracts,
melanosomes and secreted vesicles of wild-
type or uw-mutant melanocytes were
electrophoretically separated by 8% SDS-
PAGE. Tyrosinase or Tyrp1 were then
detected immunochemically with a PEP7 or
a PEP1 antibodies, respectively.
Glycosylation of melanosomal proteins was
determined following digestion with buffer
(–), EndoH (E) or PNGaseF (P), as
indicated.
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of tyrosinase to the melanosomal compartment. Tyrp1 (and to
a lesser extent Dct) was similarly disrupted from reaching the
melanosomal compartment, and this was especially apparent at
the periphery of the cells and in the dendrites, where they did
not reach early stage II melanosomes (stained green with
HMB-45).
Ultrastructural characterization of melanocytes and
melanosomes
Electron microscopy revealed that melanocytes derived from
wild-type mice contain numerous highly melanized
melanosomes (stages III and IV) with a very well-organized
structure (Fig. 5A). By contrast, uw-mutant melanocytes
contain swollen, poorly melanized melanosomes which show
an abnormal arrangement of their internal matrices, with the
majority of them being at stages I or II (Fig. 5B). DOPA
reactivity of uw-mutant melanocytes showed DOPA-positive
reactions in some of the stage I or II melanosomes, which is
evidence that at least some active tyrosinase was correctly
delivered there (Fig. 5C). Ultrastructural analysis of the
vesicles shed by uw-mutant cells revealed the presence of stage
I and II melanosomes exhibiting small amounts of melanin and
disorganized structures of their internal fibers (Fig. 5D).
Discussion
One important aspect of this study is the use of primary
melanocytes rather than immortalized cell lines to examine
the processing and subcellular localization of melanogenic
Fig. 4. Subcellular distribution of melanogenic proteins in wild-type and uw-mutant primary melanocytes. Wild-type and uw-mutant
melanocytes were stained with antibodies and fluorescent probes as noted in the Materials and Methods section, and localization of tyrosinase,
Tyrp1 or Dct (red) with KDEL or HMB-45 (green) was analyzed by confocal microscopy. Colocalization of antibodies is indicated by the
yellow color. Nuclei are identified by the blue DAPI stain. Bar, 20 m m.
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proteins. We used primary melanocytes derived from wild-type
and from Tyrc albino mice (as controls) and from uw-mutant
mice because no immortal melanocyte line is so far available
for uw-mutant OCA4 cells. Importantly, previous studies of
melanosomal protein processing and sorting have been
performed on immortalized or transformed melanocytes, and
this study has now confirmed those results for Tyr, Tyrp1 and
Dct in normal primary melanocytes. Our study represents one
of the first steps in characterizing the mechanism of OCA4
and provides important clues into the pathogenesis of that
hypopigmentary disorder. Eventually, we hope that these
OCA4 uw-mutant melanocytes will become immortalized,
which would make further studies on this type of OCA much
easier. OCA4 is a newly identified type of oculocutaneous
albinism which is associated with mutations of the underwhite
(MATP) gene and which greatly reduce or abolish tyrosinase
catalytic activity and melanin production (Lehman et al.,
2000). In this study, we analyzed the intracellular processing
and trafficking of melanogenic proteins in primary uw-mutant
melanocytes as a model for OCA type 4, focusing on
tyrosinase, the key rate-limiting enzyme in the melanin
biosynthetic pathway. Melanin synthesis in mammalian
melanocytes is the result of a complex metabolic pathway in
which at least three enzymes, known as tyrosinase-related
proteins (TRPs), are involved (Hearing and Tsukamoto, 1991;
Spritz and Hearing, 1994). Tyrosinase, Tyrp1 (originally
TRP1) and Dct (originally TRP2) are synthesized on ribosomes
and are transported through the ER and Golgi apparatus where
their post-translational processing and glycosylation take
place, as schematically presented in Fig. 5. They are then
sorted from the trans-Golgi network to early melanosomes by
secretory vesicles and are then localized in the limiting
membrane of these organelles. After the delivery of the
melanogenic enzymes to melanosomes, the synthesis of
melanin usually begins.
The biogenesis of melanosomes has gradually been
elucidated, and the earliest form of that organelle is the stage
I melanosome, which is positive for staining of gp100 with
a PEP13 (Kushimoto et al., 2001). The TRPs are not delivered
to stage I melanosomes, but rather arrive there only after the
maturation of stage I to stage II melanosomes, which is linked
to the proteolytic cleavage of gp100 (which generates the
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Fig. 5. Ultrastructure of primary melanocytes established from wild-type and from uw-mutant mice. (A) Wild-type melanocytes showing
numerous stage III and IV melanosomes. (B) uw-mutant melanocytes displaying primarily stage I and II melanosomes. (C) uw-mutant
melanocytes incubated with DOPA show a dark staining in stage I and II melanosomes (arrows), which proves the presence of active tyrosinase.
(D) Secreted vesicle fraction from uw-mutant melanocytes where stage I and II melanosomes, similar to those found in (B), are identified
clearly. Bar, 20 m m.
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Fig. 6. Melanosomal protein
trafficking and aberrant processing
seen in various types of OCA. The
disruption of tyrosinase trafficking
occurs at the level of the ER in
OCA1 and OCA3, and at the
immediate post-Golgi level in
OCA2. The results of this study
show that in OCA4, tyrosinase
processing and trafficking is
disrupted and that the enzyme is
abnormally secreted from the cells
within vesicles before delivery to
early melanosomes.
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internal fibrillar matrix). Following that cleavage, gp100
undergoes a conformational change that allows it to be
recognized by the monoclonal antibody HMB45, which thus
serves as a specific probe for identifying stage II melanosomes
(Kushimoto et al., 2001). 
According to our results, uw-mutant cells express normal
levels of tyrosinase, which is, in part, delivered to and is active
in melanosomes. At least part of the active, correctly processed
tyrosinase remains inside the melanocytes and contributes to
the low levels of melanin produced, thus explaining the
reduced but significant pigmentation seen in uw-mutant
melanocytes. However, uw-mutant melanocytes secrete into
the medium dark vesicles that contain tyrosinase, Tyrp1 and
Dct. Although metabolic labeling revealed that the amount
of tyrosinase synthesized in wild-type and uw-mutant
melanocytes is approximately the same, tyrosinase activity in
uw-mutant melanocytes is reduced to about 20% of the level
found in wild-type melanocytes due to its misrouting along
the secretory pathway. One can see using confocal
immunohistochemistry that while some of the tyrosinase in
uw-mutant cells reaches stage II (HMB45-positive)
melanosomes, most of it does not, thus leading to the
conclusion that the uw-encoded protein (MATP) functions in
the sorting of tyrosinase (and Tyrp1) from the trans-Golgi
network to stage II melanosomes. Two relevant observations
should be noted about MATP in this regard. First, MATP
obviously functions to sort only melanocyte-specific proteins
because if other common proteins were similarly affected, the
phenotype would be that of Hermansky-Pudlak syndrome
rather than of OCA (Sarangarajan et al., 2001; Huizing et al.,
2002). Second, a proteomic analysis of stage II melanosomes
recently published by our group (Basrur et al., 2003) identified
all the early melanosome-specific proteins, but MATP (and the
P protein for that matter) was conspicuous by its absence,
which suggests that both of those transport proteins function
in the sorting pathway before melanosomes. Because only
tyrosinase is secreted from OCA2 melanocytes, we
hypothesize that the function of the P protein in the sorting
pathway precedes that of MATP, as depicted in Fig. 6.
The uw-mutant melanocytes displayed a minimally
pigmented melanosome population at stages I and II; these had
irregular shapes and the internal fibers were not well organized
(Fig. 5). Similar types of early immature melanosomes were
seen in the secreted vesicle fraction. DOPA staining of uw-
mutant melanocytes showed that active tyrosinase is localized
in some of the early melanosomes of those cells. This
ultrastructural phenotype of uw-mutant melanocytes is in good
agreement with an earlier study (Lehman et al., 2000), which
reported similar features of melanosomes in cultured
melanocytes derived from mice carrying the uwd (underwhite
dense) mutation. The reduced melanin content and the irregular
shape of melanosomes in melanocytes derived from mice
carrying different mutations of the uw gene have been observed
by others (Sweet et al., 1998; Lehman et al., 2000) and could
also be seen in the eyes of those mice. This phenotype is
strikingly similar to that previously reported for OCA2
melanocytes carrying mutations in the p gene (Puri et al.,
2000). 
In conclusion, we show in this study that MATP plays a
crucial role in modulating the processing and intracellular
trafficking of tyrosinase and other melanosomal proteins. The
uw mutation is associated with a disruption of this pathway,
which results in the misrouting and abnormal release of
tyrosinase and Tyrp1 into the medium. Because tyrosinase is
the key rate-limiting enzyme of melanogenesis, this results in
the hypopigmented phenotype of uw-mutant melanocytes. The
similarity of functions of the P protein and MATP, both being
predicted transport proteins, in the trafficking of melanosomal
proteins, provides valuable clues as to the roles of such proteins
in regulating mammalian pigmentation.
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